Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

Y Li, Y Liu, S Liu, M Gao, W Wang, K Chen… - Signal transduction and …, 2023 - nature.com
Vascular complications of diabetes pose a severe threat to human health. Prevention and
treatment protocols based on a single vascular complication are no longer suitable for the …

Characteristics of peripheral arterial disease and its relevance to the diabetic population

E Faglia - The international journal of lower extremity …, 2011 - journals.sagepub.com
Peripheral arterial disease (PAD) is very frequent in diabetics, and it increases with age.
Foot examination contributes poorly to diagnosis of PAD. The ankle-brachial index (ABI) …

Cardiovascular and limb events following endovascular revascularization among patients≥ 65 years old: an American College of Cardiology PVI Registry analysis

EH Weissler, Y Wang, JM Gales… - Journal of the …, 2022 - Am Heart Assoc
Background We aimed to characterize the occurrence of major adverse cardiovascular and
limb events (MACE and MALE) among patients with peripheral artery disease (PAD) …

The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline

AM West, JD Anderson, CH Meyer, FH Epstein… - Atherosclerosis, 2011 - Elsevier
BACKGROUND: Both statins and ezetimibe lower LDL-C, but ezetimibe's effect on
atherosclerosis is controversial. We hypothesized that lowering LDL-C cholesterol by adding …

Disease location is associated with survival in patients with peripheral arterial disease

Q Chen, CY Smith, KR Bailey… - Journal of the …, 2013 - Am Heart Assoc
Background We investigated whether disease location influences survival in patients with
peripheral arterial disease. Methods and Results Patients (n= 12 731; mean age, 67.5±12.7 …

2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic …

L Mazzolai, G Teixido-Tura, S Lanzi, V Boc… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization

M Takahara, Y Soga, O Iida - European Heart Journal, 2024 - academic.oup.com
Abstract Background and Aims Patients undergoing revascularization for lower extremity
arterial disease (LEAD) may face a higher risk of mortality than those with coronary artery …

Twenty-year analysis of trends in the incidence and in-hospital mortality for lower-extremity arterial thromboembolism

R Korabathina, AR Weintraub, LL Price, NK Kapur… - Circulation, 2013 - Am Heart Assoc
Background—Epidemiology data for lower-extremity arterial thromboembolism (LET) are
limited and may result from either acute limb ischemia or an acute exacerbation of critical …

The codex of science: honesty, precision, and truth—and its violations

TF Lüscher - European Heart Journal, 2013 - academic.oup.com
Science has made enormous achievements for our understanding of the world and for
everyday life: we now know that we live on a spherical planet of the solar system, we …

A targeted literature review of the disease burden in patients with symptomatic peripheral artery disease

R Bauersachs, S Debus, M Nehler… - …, 2020 - journals.sagepub.com
Patients with peripheral artery disease (PAD) have an increased risk of cardiovascular (CV)
and limb events, but the disease is frequently underdiagnosed and treatment options are …